Gupta, Deepak

Co-Founder and Managing Partner

Patrick Scaglia

Managing General Partner and Co-Founder

Irfan Vissandjee

Principal

4 past transactions

Unnatural Products

Seed Round in 2019
Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets. Its AI-enhanced technology platform creates entirely new drugs by engineering passively permeable, macrocyclic peptides that access traditionally undruggable targets. Unnatural Products was founded in 2017 and is headquartered in Santa Cruz, California.

ImpriMed

Seed Round in 2018
ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology provides precision medicine techniques that allow veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment that can eventually be translated into human cancer care, allowing doctors to decide on a final treatment regimen based on a data-driven prediction of response success in each individual patient's body.

engageLively

Convertible Note in 2018
engageLively provides a cloud-based analytics service with a built-in visual application studio that helps firms organize, analyze, and visualize their data. They also provide arbitrary extensibility in hardware, software, memory, and storage.

DNALite Therapeutics

Seed Round in 2018
DNALite Therapeutics is an early-stage preclinical biotechnology company committed to bringing the next generation of drugs to the gastrointestinal tract. It develops oral lipid nanoparticle technology to deliver mRNA and pDNA into the intestine using the oral route of administration. Its drug aims to use the intestinal tract to secrete proteins into the bloodstream turning any protein biologic into an oral drug.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.